Ушбу иш иқтибос қилган ишлар

54 та иш

Иш: SLAMF8 (BLAME) as a novel immune checkpoint: Implications for inflammation, autoimmunity, and oncology

1. PD-1/PD-L1 pathway: current researches in cancer.

   Yanyan Han, Dandan Liu, Lianhong Li

   Мақола20203 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.430751

2. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

   Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi +3

   Шарҳ мақола20233 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458827

3. Сарлавҳасиз

   Бошқа2 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.430780

4. SLAM family receptors in normal immunity and immune pathologies

   Ning Wu, André Veillette

   Шарҳ мақола20152 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.431158

5. SLAM Family Receptor Signaling in Viral Infections: HIV and Beyond

   Patrick M. O’Connell, Andrea Amalfitano, Yasser A. Aldhamen

   Шарҳ мақола20192 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.431179

6. SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors

   Jaime De Calisto, Ninghai Wang, Guoxing Wang +3

   Мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458798

7. Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8

   Guoxing Wang, B.J. van Driel, Gongxian Liao +8

   Мақола20152 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458799

8. The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases

   Matthew A. Dragovich, Adam Mor

   Шарҳ мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458804

9. SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions

   Maren Claus, Doris Urlaub, Frank Fasbender +1

   Шарҳ мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458806

10. Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages

    Xiaokang Zeng, Guangao Liu, Wanwen Peng +6

    Мақола20182 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458807

11. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer

    Yaping Zhang, Qun Zhang, Xingzhi Han +7

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458825

12. Current understanding of CTLA-4: from mechanism to autoimmune diseases

    Md. Munnaf Hossen, Yanmei Ma, Zhihua Yin +7

    Шарҳ мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458830

13. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders

    Dominik Kľoc, Slavomír Kurhajec, Mykhailo Huniadi +3

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458834

14. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma

    Na Song, Ziwei Wang, Pingyu Shi +7

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458839

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458800

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458801

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458802

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458803

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458805

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458808

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458809

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458810

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458811

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458812

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.458813